Showing results (251-260 of 298) with videos related to

Sort By:
Pageof 30
Translational Lung Cancer Research|November 19, 2020
KRAS G12C mutations in Asia: a landscape analysis of 11,951 Chinese tumor samplesHerbert Ho-Fung Loong, Nan Du, Chunyan Cheng, et al.
Medcomm|July 14, 2026
Intracranial Efficacy of Crizotinib and Postprogression Therapeutic Strategies in Advanced c-ros Oncogene 1 (ROS1)-Positive Non-Small Cell Lung Cancer (NSCLC), a Multicenter Real-World StudyZihua Zou, Xiaobin Zheng, Panwen Tian, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 19, 2023
Endothelial Cells Are Heterogeneous in Different Brain Regions and Are Dramatically Altered in Alzheimer's DiseaseAnnie Bryant, Zhaozhi Li, Rojashree Jayakumar, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|January 7, 2005
[The contrast study between single and double balloon bilateral dilatation of kyphoplasty]Hui-lin Yang, Guo-qi Niu, Dao-chen Liang, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2019
Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinibJun Zhao, Gen Lin, Minglei Zhuo, et al.
Thoracic Cancer|June 8, 2025
Chinese Expert Consensus on Leptomeningeal Metastases of Lung CancerGen Lin, Yongsheng Wang, Tao Xin, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2023
Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancerYiquan Xu, Jingjing Yan, Chengzhi Zhou, et al.
Nature Neuroscience|April 18, 2017
A new fate mapping system reveals context-dependent random or clonal expansion of microgliaTuan Leng Tay, Dominic Mai, Jana Dautzenberg, et al.
The Oncologist|May 31, 2022
Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901)Wenying Peng, Liming Cao, Likun Chen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 3, 2021
Comparing Patient-Controlled Analgesia Versus Non-PCA Hydromorphone Titration for Severe Cancer Pain: A Randomized Phase III TrialRongbo Lin, Sunzhi Lin, Shuitu Feng, et al.
Pageof 30